article thumbnail

Microbiological Applications: Bacterial Metabolism | BMG LABTECH

BMG Labtech

2015) Regulating the intersection of metabolism and pathogenesis in Gram-positive bacteria. 2 in this blog adapted from this reference under license CC-BY 4.0. WH Freeman and Company, San Francisco. Richardson AR, Somerville GA, Sonenshein AL. Microbiology Spectrum 3(3):MBP-0004-2014. doi: 10.1128/microbiolspec.MBP-0004-2014.

article thumbnail

Elacestrant 

New Drug Approvals

Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer” at ClinicalTrials.gov ^ Jump up to: a b c Wardell SE, Nelson ER, Chao CA, Alley HM, McDonnell DP (October 2015). Jump up to: a b c Garner F, Shomali M, Paquin D, Lyttle CR, Hattersley G (October 2015). 22 (5): 713724. doi : 10.1530/ERC-15-0287.

FDA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gepirone

New Drug Approvals

5] History Gepirone was developed by Bristol-Myers Squibb in 1986, [5] but was out-licensed to Fabre-Kramer in 1993. 5] In December 2015, the FDA once again gave gepirone a negative review for depression due to concerns of efficacy. [12] Firth S (30 November 2015). 1] It is taken orally. [1] 5] SYN Synthesis Ormaza, V. .

FDA
article thumbnail

Vamorolone

New Drug Approvals

2015 Apr;35(3):377-387. [Content Brief] [2]. Dillingham BC, et al. VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. Cell Mol Neurobiol. Content Brief] [3]. Heier CR, et al. Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.

FDA
article thumbnail

Zilucoplan

New Drug Approvals

. “Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis” Expert Opinion on Investigational Drugs. 30 (5): 483–493. doi : 10.1080/13543784.2021.1897567. hdl : 11250/2770699. PMID 33792453. S2CID 232482753. 126 (23): 939.

FDA
article thumbnail

Landiolol

New Drug Approvals

Okajima M, Takamura M, Taniguchi T (August 2015). March 2015). . “The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors” British Journal of Pharmacology. 144 (3): 31722. doi : 10.1038/sj.bjp.0706048. PMC 1576008. PMID 15655528. 4 (3): 2517. doi : 10.5492/wjccm.v4.i3.251.

FDA
article thumbnail

Swiss startup LimmaTech licenses GSK vaccine, hires ex-CureVac chief as CEO

BioPharma Drive: Drug Pricing

The startup will take on development of a shigellosis vaccine GSK inherited when it acquired LimmaTech’s predecessor, GlycoVaxyn, in 2015.